450 participants
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-03
- Start Date:
- 2023-05-01
- Completion:
- 2028-03-31
Conditions
- Episodic Migraine
Interventions
- DRUG
No Results Yet